{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:26:09Z","timestamp":1777879569341,"version":"3.51.4"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Postgraduate Research & Practice Innovation Program of Harbin Medical University","award":["YJSCX2023-64HYD"],"award-info":[{"award-number":["YJSCX2023-64HYD"]}]},{"name":"Youth Fund Project of Harbin Medical University","award":["2023-KYYWF-0164"],"award-info":[{"award-number":["2023-KYYWF-0164"]}]},{"name":"the Foundation of the First Affiliated Hospital of Harbin Medical University","award":["2023B11"],"award-info":[{"award-number":["2023B11"]}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province of China","doi-asserted-by":"crossref","award":["YQ2020H012"],"award-info":[{"award-number":["YQ2020H012"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province of China","doi-asserted-by":"crossref","award":["JJ2024LH0246"],"award-info":[{"award-number":["JJ2024LH0246"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chen Xiao-ping Foundation for the Development of Science and Technology of Hubei Province","award":["CXPJJH11900018-2003"],"award-info":[{"award-number":["CXPJJH11900018-2003"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270668"],"award-info":[{"award-number":["82270668"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Science Fund for Distinguished Young Scholars of First Affiliated Hospital of Harbin Medical University","award":["HYD2020JQ0010"],"award-info":[{"award-number":["HYD2020JQ0010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10495-026-02335-w","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T12:36:35Z","timestamp":1776429395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The GATA3-RFPL3-ASK1 axis suppresses breast cancer growth and lung metastasis"],"prefix":"10.1007","volume":"31","author":[{"given":"Kang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Hui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ting","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Zhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-Yao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le-Min","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-Qing","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"2335_CR1","doi-asserted-by":"crossref","unstructured":"Global cancer burden growing, amidst mounting need for services (2024). Saudi Med J 45(3):326\u2013327.","DOI":"10.15537\/1658-3175.8333"},{"issue":"3","key":"2335_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2335_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck N, Penault-Llorca F, Cortes J et al (2019) Breast cancer. Nat Rev Dis Primers 5(1):66. https:\/\/doi.org\/10.1038\/s41572-019-0111-2","journal-title":"Nat Rev Dis Primers"},{"issue":"38","key":"2335_CR4","doi-asserted-by":"publisher","first-page":"26368","DOI":"10.1074\/jbc.M114.561662","volume":"289","author":"BH Tan","year":"2014","unstructured":"Tan BH, Suzuki Y, Takahashi H et al (2014) Identification of RFPL3 protein as a novel E3 ubiquitin ligase modulating the integration activity of human immunodeficiency virus, type 1 preintegration complex using a microtiter plate-based assay. J Biol Chem 289(38):26368\u201326382. https:\/\/doi.org\/10.1074\/jbc.M114.561662","journal-title":"J Biol Chem"},{"issue":"9","key":"2335_CR5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1101\/gr.9.9.803","volume":"9","author":"E Seroussi","year":"1999","unstructured":"Seroussi E, Kedra D, Pan HQ et al (1999) Duplications on human chromosome 22 reveal a novel ret finger protein-like gene family with sense and endogenous antisense transcripts. Genome Res 9(9):803\u2013814. https:\/\/doi.org\/10.1101\/gr.9.9.803","journal-title":"Genome Res"},{"issue":"2","key":"2335_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ajhg.2008.07.007","volume":"83","author":"J Bonnefont","year":"2008","unstructured":"Bonnefont J, Nikolaev SI, Perrier AL et al (2008) Evolutionary forces shape the human RFPL1,2,3 genes toward a role in neocortex development. Am J Hum Genet 83(2):208\u2013218. https:\/\/doi.org\/10.1016\/j.ajhg.2008.07.007","journal-title":"Am J Hum Genet"},{"issue":"11","key":"2335_CR7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nri2413","volume":"8","author":"K Ozato","year":"2008","unstructured":"Ozato K, Shin DM, Chang TH et al (2008) TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol 8(11):849\u2013860. https:\/\/doi.org\/10.1038\/nri2413","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2335_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039306","volume":"7","author":"S Assou","year":"2012","unstructured":"Assou S, Boumela I, Haouzi D et al (2012) Transcriptome analysis during human trophectoderm specification suggests new roles of metabolic and epigenetic genes. PLoS ONE 7(6):e39306. https:\/\/doi.org\/10.1371\/journal.pone.0039306","journal-title":"PLoS ONE"},{"issue":"10","key":"2335_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03101-9","volume":"11","author":"BA Zohud","year":"2020","unstructured":"Zohud BA, Guo P, Zohud BA et al (2020) Importin 13 promotes NSCLC progression by mediating RFPL3 nuclear translocation and hTERT expression upregulation. Cell Death Dis 11(10):879. https:\/\/doi.org\/10.1038\/s41419-020-03101-9","journal-title":"Cell Death Dis"},{"key":"2335_CR10","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1016\/j.csbj.2022.07.008","volume":"20","author":"AK Agrahari","year":"2022","unstructured":"Agrahari AK, Dikshit M, Asthana S (2022) Crystallographic mining of ASK1 regulators to unravel the intricate PPI interfaces for the discovery of small molecule. Comput Struct Biotechnol J 20:3734\u20133754. https:\/\/doi.org\/10.1016\/j.csbj.2022.07.008","journal-title":"Comput Struct Biotechnol J"},{"key":"2335_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101400","volume":"29","author":"N Shu","year":"2020","unstructured":"Shu N, H\u00e4gglund P, Cai H et al (2020) Modification of Cys residues in human thioredoxin-1 by p-benzoquinone causes inhibition of its catalytic activity and activation of the ASK1\/p38-MAPK signalling pathway. Redox Biol 29:101400. https:\/\/doi.org\/10.1016\/j.redox.2019.101400","journal-title":"Redox Biol"},{"issue":"48","key":"2335_CR12","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1038\/onc.2009.276","volume":"28","author":"JJ Gu","year":"2009","unstructured":"Gu JJ, Wang Z, Reeves R et al (2009) PIM1 phosphorylates and negatively regulates ASK1-mediated apoptosis. Oncogene 28(48):4261\u20134271. https:\/\/doi.org\/10.1038\/onc.2009.276","journal-title":"Oncogene"},{"issue":"30","key":"2335_CR13","doi-asserted-by":"publisher","first-page":"12301","DOI":"10.1073\/pnas.0901823106","volume":"106","author":"K Takeda","year":"2009","unstructured":"Takeda K, Komuro Y, Hayakawa T et al (2009) Mitochondrial phosphoglycerate mutase 5 uses alternate catalytic activity as a protein serine\/threonine phosphatase to activate ASK1. Proc Natl Acad Sci U S A 106(30):12301\u201312305. https:\/\/doi.org\/10.1073\/pnas.0901823106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2335_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072346","volume":"21","author":"J Yue","year":"2020","unstructured":"Yue J, L\u00f3pez JM (2020) Understanding MAPK signaling pathways in apoptosis. Int J Mol Sci 21(7):2346. https:\/\/doi.org\/10.3390\/ijms21072346","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2335_CR15","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1517\/13543780903321490","volume":"18","author":"HY Yong","year":"2009","unstructured":"Yong HY, Koh MS, Moon A (2009) The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer. Expert Opin Investig Drugs 18(12):1893\u20131905. https:\/\/doi.org\/10.1517\/13543780903321490","journal-title":"Expert Opin Investig Drugs"},{"issue":"9\u201310","key":"2335_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1177\/1947601913507951","volume":"4","author":"HK Koul","year":"2013","unstructured":"Koul HK, Pal M, Koul S (2013) Role of p38 MAP kinase signal transduction in solid tumors. Genes Cancer 4(9\u201310):342\u2013359. https:\/\/doi.org\/10.1177\/1947601913507951","journal-title":"Genes Cancer"},{"issue":"34","key":"2335_CR17","doi-asserted-by":"publisher","first-page":"26576","DOI":"10.1074\/jbc.M003412200","volume":"275","author":"T Hatai","year":"2000","unstructured":"Hatai T, Matsuzawa A, Inoshita S et al (2000) Execution of apoptosis signal-regulating kinase 1 (ASK1)-induced apoptosis by the mitochondria-dependent caspase activation. J Biol Chem 275(34):26576\u201326581. https:\/\/doi.org\/10.1074\/jbc.M003412200","journal-title":"J Biol Chem"},{"issue":"1","key":"2335_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/jcp.21943","volume":"222","author":"J Chou","year":"2010","unstructured":"Chou J, Provot S, Werb Z (2010) GATA3 in development and cancer differentiation: cells GATA have it! J Cell Physiol 222(1):42\u201349. https:\/\/doi.org\/10.1002\/jcp.21943","journal-title":"J Cell Physiol"},{"issue":"5","key":"2335_CR19","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/PAP.0b013e3182a28a68","volume":"20","author":"NG Ord\u00f3\u00f1ez","year":"2013","unstructured":"Ord\u00f3\u00f1ez NG (2013) Value of GATA3 immunostaining in tumor diagnosis: a review. Adv Anat Pathol 20(5):352\u2013360. https:\/\/doi.org\/10.1097\/PAP.0b013e3182a28a68","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"2335_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","volume":"38","author":"M Miettinen","year":"2014","unstructured":"Miettinen M, McCue PA, Sarlomo-Rikala M et al (2014) GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol 38(1):13\u201322. https:\/\/doi.org\/10.1097\/PAS.0b013e3182a0218f","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"2335_CR21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/ncb2672","volume":"15","author":"J Chou","year":"2013","unstructured":"Chou J, Lin JH, Brenot A et al (2013) GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression. Nat Cell Biol 15(2):201\u2013213. https:\/\/doi.org\/10.1038\/ncb2672","journal-title":"Nat Cell Biol"},{"issue":"18","key":"2335_CR22","doi-asserted-by":"publisher","first-page":"14042","DOI":"10.1074\/jbc.M110.105262","volume":"285","author":"W Yan","year":"2010","unstructured":"Yan W, Cao QJ, Arenas RB et al (2010) GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition. J Biol Chem 285(18):14042\u201314051. https:\/\/doi.org\/10.1074\/jbc.M110.105262","journal-title":"J Biol Chem"},{"issue":"11","key":"2335_CR23","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1172\/JCI57456","volume":"121","author":"EA Wohlfert","year":"2011","unstructured":"Wohlfert EA, Grainger JR, Bouladoux N et al (2011) GATA3 controls Foxp3\u207a regulatory T cell fate during inflammation in mice. J Clin Invest 121(11):4503\u20134515. https:\/\/doi.org\/10.1172\/JCI57456","journal-title":"J Clin Invest"},{"issue":"1","key":"2335_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1309\/AJCP5UAFMSA9ZQBZ","volume":"138","author":"H Liu","year":"2012","unstructured":"Liu H, Shi J, Wilkerson ML et al (2012) Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. Am J Clin Pathol 138(1):57\u201364. https:\/\/doi.org\/10.1309\/AJCP5UAFMSA9ZQBZ","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"2335_CR25","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1093\/annonc\/mds120","volume":"23","author":"N Tominaga","year":"2012","unstructured":"Tominaga N, Naoi Y, Shimazu K et al (2012) Clinicopathological analysis of GATA3-positive breast cancers with special reference to response to neoadjuvant chemotherapy. Ann Oncol 23(12):3051\u20133057. https:\/\/doi.org\/10.1093\/annonc\/mds120","journal-title":"Ann Oncol"},{"issue":"4","key":"2335_CR26","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00428-015-1894-5","volume":"468","author":"KW Min","year":"2016","unstructured":"Min KW, Kim DH, Do SI et al (2016) Negative association between GATA3 and fascin could predict relapse-free and overall survival in patients with breast cancer. Virchows Arch 468(4):409\u2013416. https:\/\/doi.org\/10.1007\/s00428-015-1894-5","journal-title":"Virchows Arch"},{"issue":"9","key":"2335_CR27","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1097\/PAS.0000000000000505","volume":"39","author":"G Deftereos","year":"2015","unstructured":"Deftereos G, Sanguino Ramirez AM, Silverman JF et al (2015) GATA3 immunohistochemistry expression in histologic subtypes of primary breast carcinoma and metastatic breast carcinoma cytology. Am J Surg Pathol 39(9):1282\u20131289. https:\/\/doi.org\/10.1097\/PAS.0000000000000505","journal-title":"Am J Surg Pathol"},{"issue":"29","key":"2335_CR28","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1038\/onc.2009.126","volume":"28","author":"AB Dydensborg","year":"2009","unstructured":"Dydensborg AB, Rose AA, Wilson BJ et al (2009) GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis. Oncogene 28(29):2634\u20132642. https:\/\/doi.org\/10.1038\/onc.2009.126","journal-title":"Oncogene"},{"issue":"8","key":"2335_CR29","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.molcel.2022.02.004","volume":"82","author":"D Sherpa","year":"2022","unstructured":"Sherpa D, Chrustowicz J, Schulman BA (2022) How the ends signal the end: regulation by E3 ubiquitin ligases recognizing protein termini. Mol Cell 82(8):1424\u20131438. https:\/\/doi.org\/10.1016\/j.molcel.2022.02.004","journal-title":"Mol Cell"},{"key":"2335_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1146\/annurev-biochem-061516-044916","volume":"86","author":"TET Mevissen","year":"2017","unstructured":"Mevissen TET, Komander D (2017) Mechanisms of deubiquitinase specificity and regulation. Annu Rev Biochem 86:159\u2013192. https:\/\/doi.org\/10.1146\/annurev-biochem-061516-044916","journal-title":"Annu Rev Biochem"},{"issue":"5","key":"2335_CR31","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41580-021-00448-5","volume":"23","author":"DA Cruz Walma","year":"2022","unstructured":"Cruz Walma DA, Chen Z, Bullock AN et al (2022) Ubiquitin ligases: guardians of mammalian development. Nat Rev Mol Cell Biol 23(5):350\u2013367. https:\/\/doi.org\/10.1038\/s41580-021-00448-5","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"2335_CR32","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1002\/hep.30705","volume":"70","author":"ZZ Yan","year":"2019","unstructured":"Yan ZZ, Huang YP, Wang X et al (2019) Integrated omics reveals Tollip as an regulator and therapeutic target for hepatic ischemia-reperfusion injury in mice. Hepatology 70(5):1750\u20131769. https:\/\/doi.org\/10.1002\/hep.30705","journal-title":"Hepatology"},{"key":"2335_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2018.05.002","volume":"39","author":"T Meirson","year":"2018","unstructured":"Meirson T, Gil-Henn H (2018) Targeting invadopodia for blocking breast cancer metastasis. Drug Resist Updat 39:1\u201317. https:\/\/doi.org\/10.1016\/j.drup.2018.05.002","journal-title":"Drug Resist Updat"},{"issue":"29","key":"2335_CR34","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.1038\/s41388-021-01873-8","volume":"40","author":"X Bi","year":"2021","unstructured":"Bi X, Lou P, Song Y et al (2021) Msi1 promotes breast cancer metastasis by regulating invadopodia-mediated extracellular matrix degradation via the Timp3-Mmp9 pathway. Oncogene 40(29):4832\u20134845. https:\/\/doi.org\/10.1038\/s41388-021-01873-8","journal-title":"Oncogene"},{"issue":"3","key":"2335_CR35","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ccr.2011.01.036","volume":"19","author":"MA Eckert","year":"2011","unstructured":"Eckert MA, Lwin TM, Chang AT et al (2011) Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell 19(3):372\u2013386. https:\/\/doi.org\/10.1016\/j.ccr.2011.01.036","journal-title":"Cancer Cell"},{"issue":"3","key":"2335_CR36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15(3):178\u2013196. https:\/\/doi.org\/10.1038\/nrm3758","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"2335_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113302","volume":"42","author":"M Bukhari","year":"2023","unstructured":"Bukhari M, Patel N, Fontana R et al (2023) Fibroblast activation protein drives tumor metastasis via a protease-independent role in invadopodia stabilization. Cell Rep 42(10):113302. https:\/\/doi.org\/10.1016\/j.celrep.2023.113302","journal-title":"Cell Rep"},{"issue":"8","key":"2335_CR38","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2694","volume":"9","author":"EF Wagner","year":"2009","unstructured":"Wagner EF, Nebreda AR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9(8):537\u2013549. https:\/\/doi.org\/10.1038\/nrc2694","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"2335_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102167","volume":"9","author":"B Humphries","year":"2020","unstructured":"Humphries B, Wang Z, Yang C (2020) Rho GTPases: big players in breast cancer initiation, metastasis and therapeutic responses. Cells 9(10):2167. https:\/\/doi.org\/10.3390\/cells9102167","journal-title":"Cells"},{"key":"2335_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.semcancer.2019.08.003","volume":"62","author":"K Karamanou","year":"2020","unstructured":"Karamanou K, Franchi M, Vynios D et al (2020) Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulator. Semin Cancer Biol 62:125\u2013133. https:\/\/doi.org\/10.1016\/j.semcancer.2019.08.003","journal-title":"Semin Cancer Biol"},{"issue":"24","key":"2335_CR41","doi-asserted-by":"publisher","first-page":"11259","DOI":"10.1158\/0008-5472.CAN-05-2495","volume":"65","author":"R Mehra","year":"2005","unstructured":"Mehra R, Varambally S, Ding L et al (2005) Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. Cancer Res 65(24):11259\u201311264. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-2495","journal-title":"Cancer Res"},{"issue":"2","key":"2335_CR42","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ccr.2008.01.011","volume":"13","author":"H Kouros-Mehr","year":"2008","unstructured":"Kouros-Mehr H, Bechis SK, Slorach EM et al (2008) GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell 13(2):141\u2013152. https:\/\/doi.org\/10.1016\/j.ccr.2008.01.011","journal-title":"Cancer Cell"},{"issue":"6","key":"2335_CR43","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ccell.2015.04.011","volume":"27","author":"W Si","year":"2015","unstructured":"Si W, Huang W, Zheng Y et al (2015) Dysfunction of the reciprocal feedback loop between GATA3- and ZEB2-nucleated repression programs contributes to breast cancer metastasis. Cancer Cell 27(6):822\u2013836. https:\/\/doi.org\/10.1016\/j.ccell.2015.04.011","journal-title":"Cancer Cell"},{"issue":"6","key":"2335_CR44","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41556-020-0514-z","volume":"22","author":"M Bi","year":"2020","unstructured":"Bi M, Zhang Z, Jiang YZ et al (2020) Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance. Nat Cell Biol 22(6):701\u2013715. https:\/\/doi.org\/10.1038\/s41556-020-0514-z","journal-title":"Nat Cell Biol"},{"issue":"9","key":"2335_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006279","volume":"12","author":"B Mair","year":"2016","unstructured":"Mair B, Konopka T, Kerzendorfer C et al (2016) Gain- and loss-of-function mutations in the breast cancer gene GATA3 result in differential drug sensitivity. PLoS Genet 12(9):e1006279. https:\/\/doi.org\/10.1371\/journal.pgen.1006279","journal-title":"PLoS Genet"},{"issue":"8","key":"2335_CR46","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1002\/ijc.34119","volume":"151","author":"Z Li","year":"2022","unstructured":"Li Z, Jia Y, Zhu H et al (2022) Genomic landscape of microsatellite instability in Chinese tumors: a comparison of Chinese and TCGA cohorts. Int J Cancer 151(8):1382\u20131393. https:\/\/doi.org\/10.1002\/ijc.34119","journal-title":"Int J Cancer"},{"issue":"7403","key":"2335_CR47","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nature11154","volume":"486","author":"S Banerji","year":"2012","unstructured":"Banerji S, Cibulskis K, Rangel-Escareno C et al (2012) Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 486(7403):405\u2013409. https:\/\/doi.org\/10.1038\/nature11154","journal-title":"Nature"},{"issue":"7757","key":"2335_CR48","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41586-019-1056-z","volume":"569","author":"F Bertucci","year":"2019","unstructured":"Bertucci F, Ng CKY, Patsouris A et al (2019) Genomic characterization of metastatic breast cancers. Nature 569(7757):560\u2013564. https:\/\/doi.org\/10.1038\/s41586-019-1056-z","journal-title":"Nature"},{"issue":"17","key":"2335_CR49","doi-asserted-by":"publisher","first-page":"8218","DOI":"10.7150\/thno.59280","volume":"11","author":"F Bai","year":"2021","unstructured":"Bai F, Zhang LH, Liu X et al (2021) GATA3 functions downstream of BRCA1 to suppress EMT in breast cancer. Theranostics 11(17):8218\u20138233. https:\/\/doi.org\/10.7150\/thno.59280","journal-title":"Theranostics"},{"issue":"1","key":"2335_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03478-4","volume":"9","author":"M Takaku","year":"2018","unstructured":"Takaku M, Grimm SA, Roberts JD et al (2018) GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network. Nat Commun 9(1):1059. https:\/\/doi.org\/10.1038\/s41467-018-03478-4","journal-title":"Nat Commun"},{"issue":"10","key":"2335_CR51","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.str.2007.08.011","volume":"15","author":"G Bunkoczi","year":"2007","unstructured":"Bunkoczi G, Salah E, Filippakopoulos P et al (2007) Structural and functional characterization of the human protein kinase ASK1. Structure 15(10):1215\u20131226. https:\/\/doi.org\/10.1016\/j.str.2007.08.011","journal-title":"Structure"},{"issue":"5296","key":"2335_CR52","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1126\/science.275.5296.90","volume":"275","author":"H Ichijo","year":"1997","unstructured":"Ichijo H, Nishida E, Irie K et al (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK\/JNK and p38 signaling pathways. Science 275(5296):90\u201394. https:\/\/doi.org\/10.1126\/science.275.5296.90","journal-title":"Science"},{"issue":"1","key":"2335_CR53","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/hep.30822","volume":"71","author":"Y Wang","year":"2020","unstructured":"Wang Y, Wen H, Fu J et al (2020) Hepatocyte TNF receptor-associated factor 6 aggravates hepatic inflammation and fibrosis by promoting lysine 6-linked polyubiquitination of apoptosis signal-regulating kinase 1. Hepatology 71(1):93\u2013111. https:\/\/doi.org\/10.1002\/hep.30822","journal-title":"Hepatology"},{"key":"2335_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00167","volume":"10","author":"A Fra","year":"2017","unstructured":"Fra A, Yoboue ED, Sitia R (2017) Cysteines as redox molecular switches and targets of disease. Front Mol Neurosci 10:167. https:\/\/doi.org\/10.3389\/fnmol.2017.00167","journal-title":"Front Mol Neurosci"},{"issue":"9","key":"2335_CR55","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1093\/emboj\/17.9.2596","volume":"17","author":"M Saitoh","year":"1998","unstructured":"Saitoh M, Nishitoh H, Fujii M (1998) Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17(9):2596\u20132606. https:\/\/doi.org\/10.1093\/emboj\/17.9.2596","journal-title":"EMBO J"},{"issue":"13","key":"2335_CR56","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.febslet.2008.05.015","volume":"582","author":"SY Kim","year":"2008","unstructured":"Kim SY, Kim TJ, Lee KY (2008) A novel function of peroxiredoxin 1 (Prx-1) in apoptosis signal-regulating kinase 1 (ASK1)-mediated signaling pathway. FEBS Lett 582(13):1913\u20131918. https:\/\/doi.org\/10.1016\/j.febslet.2008.05.015","journal-title":"FEBS Lett"},{"issue":"Pt 3","key":"2335_CR57","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1042\/BJ20030275","volume":"373","author":"JJ Song","year":"2003","unstructured":"Song JJ, Lee YJ (2003) Differential role of glutaredoxin and thioredoxin in metabolic oxidative stress-induced activation of apoptosis signal-regulating kinase 1. Biochem J 373(Pt 3):845\u2013853. https:\/\/doi.org\/10.1042\/BJ20030275","journal-title":"Biochem J"},{"issue":"20","key":"2335_CR58","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1111\/febs.13893","volume":"283","author":"S Kylarova","year":"2016","unstructured":"Kylarova S, Kosek D, Petrvalska O et al (2016) Cysteine residues mediate high-affinity binding of thioredoxin to ASK1. FEBS J 283(20):3821\u20133838. https:\/\/doi.org\/10.1111\/febs.13893","journal-title":"FEBS J"},{"issue":"1","key":"2335_CR59","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/jcp.10080","volume":"191","author":"K Tobiume","year":"2002","unstructured":"Tobiume K, Saitoh M, Ichijo H (2002) Activation of apoptosis signal-regulating kinase 1 by the stress-induced activating phosphorylation of pre-formed oligomer. J Cell Physiol 191(1):95\u2013104. https:\/\/doi.org\/10.1002\/jcp.10080","journal-title":"J Cell Physiol"},{"issue":"23","key":"2335_CR60","doi-asserted-by":"publisher","first-page":"8152","DOI":"10.1128\/MCB.00227-07","volume":"27","author":"G Fujino","year":"2007","unstructured":"Fujino G, Noguchi T, Matsuzawa A et al (2007) Thioredoxin and TRAF family proteins regulate reactive oxygen species-dependent activation of ASK1 through reciprocal modulation of the N-terminal homophilic interaction of ASK1. Mol Cell Biol 27(23):8152\u20138163. https:\/\/doi.org\/10.1128\/MCB.00227-07","journal-title":"Mol Cell Biol"},{"issue":"12","key":"2335_CR61","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.yexcr.2011.03.022","volume":"317","author":"KT Noh","year":"2011","unstructured":"Noh KT, Park YM, Cho SG et al (2011) GSK-3\u03b2-induced ASK1 stabilization is crucial in LPS-induced endotoxin shock. Exp Cell Res 317(12):1663\u20131668. https:\/\/doi.org\/10.1016\/j.yexcr.2011.03.022","journal-title":"Exp Cell Res"},{"key":"2335_CR62","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.14087","volume":"5","author":"Z Yu","year":"2016","unstructured":"Yu Z, Chen T, Li X et al (2016) Lys29-linkage of ASK1 by Skp1-Cullin 1-Fbxo21 ubiquitin ligase complex is required for antiviral innate response. Elife 5:e14087. https:\/\/doi.org\/10.7554\/eLife.14087","journal-title":"Elife"},{"key":"2335_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117214","volume":"178","author":"B Wang","year":"2024","unstructured":"Wang B, Ma Y, Zhang Y et al (2024) Therapeutic potential of ASK1 activators in cancer treatment: current insights and future directions. Biomed Pharmacother 178:117214. https:\/\/doi.org\/10.1016\/j.biopha.2024.117214","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"2335_CR64","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011254","volume":"4","author":"DK Morrison","year":"2012","unstructured":"Morrison DK (2012) MAP kinase pathways. Cold Spring Harb Perspect Biol 4(11):a011254. https:\/\/doi.org\/10.1101\/cshperspect.a011254","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"2335_CR65","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/sj.cr.7290262","volume":"15","author":"J Liu","year":"2005","unstructured":"Liu J, Lin A (2005) Role of JNK activation in apoptosis: a double-edged sword. Cell Res 15(1):36\u201342. https:\/\/doi.org\/10.1038\/sj.cr.7290262","journal-title":"Cell Res"},{"issue":"1","key":"2335_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14010104","volume":"14","author":"R Dong","year":"2025","unstructured":"Dong R, Wang J, Guan R et al (2025) Role of oxidative stress in the occurrence, development, and treatment of breast cancer. Antioxidants 14(1):104. https:\/\/doi.org\/10.3390\/antiox14010104","journal-title":"Antioxidants"},{"key":"2335_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103028","volume":"70","author":"K Lewis","year":"2024","unstructured":"Lewis K, La Selva R, Maldonado E et al (2024) p66ShcA promotes malignant breast cancer phenotypes by alleviating energetic and oxidative stress. Redox Biol 70:103028. https:\/\/doi.org\/10.1016\/j.redox.2024.103028","journal-title":"Redox Biol"},{"issue":"1","key":"2335_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01398-5","volume":"22","author":"MJ Iqbal","year":"2024","unstructured":"Iqbal MJ, Kabeer A, Abbas Z et al (2024) Interplay of oxidative stress, cellular communication and signaling pathways in cancer. Cell Commun Signal 22(1):7. https:\/\/doi.org\/10.1186\/s12964-023-01398-5","journal-title":"Cell Commun Signal"},{"issue":"21","key":"2335_CR69","doi-asserted-by":"publisher","first-page":"8347","DOI":"10.1158\/0008-5472.CAN-09-4149","volume":"70","author":"CS Pichot","year":"2010","unstructured":"Pichot CS, Arvanitis C, Hartig SM et al (2010) Cdc42-interacting protein 4 promotes breast cancer cell invasion and formation of invadopodia through activation of N-WASp. Cancer Res 70(21):8347\u20138356. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-4149","journal-title":"Cancer Res"},{"issue":"3","key":"2335_CR70","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.devcel.2018.12.018","volume":"48","author":"LC Kelley","year":"2019","unstructured":"Kelley LC, Chi Q, C\u00e1ceres R et al (2019) Adaptive F-Actin polymerization and localized ATP production drive basement membrane invasion in the absence of MMPs. Dev Cell 48(3):313-328.e8. https:\/\/doi.org\/10.1016\/j.devcel.2018.12.018","journal-title":"Dev Cell"},{"issue":"1\u20132","key":"2335_CR71","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10555-008-9169-0","volume":"28","author":"M Yilmaz","year":"2009","unstructured":"Yilmaz M, Christofori G (2009) EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 28(1\u20132):15\u201333. https:\/\/doi.org\/10.1007\/s10555-008-9169-0","journal-title":"Cancer Metastasis Rev"},{"key":"2335_CR72","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.canlet.2020.03.018","volume":"483","author":"S Qi","year":"2020","unstructured":"Qi S, Perrino S, Miao X et al (2020) The chemokine CCL7 regulates invadopodia maturation and MMP-9 mediated collagen degradation in liver-metastatic carcinoma cells. Cancer Lett 483:98\u2013113. https:\/\/doi.org\/10.1016\/j.canlet.2020.03.018","journal-title":"Cancer Lett"},{"issue":"Pt 20","key":"2335_CR73","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1242\/jcs.126573","volume":"126","author":"A Jacob","year":"2013","unstructured":"Jacob A, Jing J, Lee J et al (2013) Rab40b regulates trafficking of MMP2 and MMP9 during invadopodia formation and invasion of breast cancer cells. J Cell Sci 126(Pt 20):4647\u20134658. https:\/\/doi.org\/10.1242\/jcs.126573","journal-title":"J Cell Sci"},{"issue":"9","key":"2335_CR74","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.1158\/0008-5472.CAN-06-3928","volume":"67","author":"ES Clark","year":"2007","unstructured":"Clark ES, Whigham AS, Yarbrough WG et al (2007) Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res 67(9):4227\u20134235. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-3928","journal-title":"Cancer Res"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02335-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02335-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02335-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:47:24Z","timestamp":1777592844000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02335-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2335"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02335-w","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors hereby declare that there are no financial interests, personal relationships, or other potential conflicts of interest that could influence the objectivity of this study\u2019s design, implementation, data analysis, or manuscript preparation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors did not utilize AI for any generative editorial tasks or autonomous content generation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI Use Declaration"}}],"article-number":"127"}}